Spirulina and NK Cell Biology: NKG2D, KIR Receptors, and Innate Cytotoxicity

NK Cell Activation Receptors

NK cells are innate lymphoid cells that kill virus-infected, tumour-transformed, and stressed cells. Activation is governed by a balance between activating receptors (NKG2D/KLRK1, NKp30/NCR3, NKp44/NCR2, NKp46/NCR1, DNAM-1/CD226, 2B4/CD244) and inhibitory receptors (KIRs: KIR2DL1/2/3 binding HLA-C; KIR3DL1/2 binding HLA-Bw4; NKG2A/CD94 heterodimer binding HLA-E). The missing-self hypothesis: loss of HLA class I (by virus/tumour) removes KIR inhibitory signals, allowing activation receptors to trigger cytotoxicity.

NKG2D-MICA/B Axis and Stress Ligand Induction

NKG2D (KLRK1) is an activating homodimer associating with DAP10 (HCST, PI3K/Grb2 recruiting) or DAP12 (TYROBP, ITAM/Syk/ZAP70 recruiting). Its ligands, MICA, MICB, and ULBP1-6, are induced on stressed cells by: DNA damage (ATM/ATR activation, via ARE-like and E2F promoter elements), heat shock, viral infection, and oxidative stress. Spirulina's Nrf2 activation and DNA damage reduction may paradoxically reduce NKG2D ligand expression on healthy bystander cells (protecting them from NK killing) while tumour cells with constitutive DNA damage maintain high MICA/B. This selective effect is consistent with spirulina's reported host-protective anti-tumour activity.

Cytotoxic Granule Release: Perforin and Granzymes

Upon target recognition, NK cells form an immunological synapse, polarise lytic granules containing perforin-1 (PRF1) and granzymes (GZMA/B/K/M/H) toward the synapse, and release them by exocytosis (regulated secretion via UNC13D/RAB27A). Perforin inserts into the target cell membrane (Ca2+-dependent, MACPF domain), forming pores through which granzyme B (Asp-Asp-Glu/DEVD cleavage preference, activating caspase-3 directly) and granzyme A (GZMA, tryptase, cleaving histones and GADPH) enter to trigger apoptosis. Spirulina C-phycocyanin enhances NK cytotoxic activity in multiple rodent studies, correlating with elevated NK granule release and perforin/granzyme B expression.

ADCC: FcgammaRIII and IgG-Coated Targets

NK cells express CD16 (FcgammaRIIIA/CD16A), a low-affinity Fc receptor for IgG that enables antibody-dependent cellular cytotoxicity (ADCC). IgG-coated targets activate CD16, triggering the same cytotoxic granule release pathway as NKG2D, plus TRAIL and FasL-mediated apoptosis. ADCC is particularly relevant for therapeutic antibodies (rituximab, trastuzumab, cetuximab). Spirulina's immunomodulatory polysaccharides activate NK cells independently of antibody opsonisation, providing complementary non-ADCC innate cytotoxicity.

NK Cell Metabolism: mTOR, AMPK, and Activation

Upon cytokine activation (IL-15, IL-12, IL-18), NK cells shift to glycolysis and oxidative phosphorylation via mTORC1 (rapamycin-sensitive). mTORC1 drives glucose transporter GLUT1 upregulation, necessary for the metabolic burst of cytokine production and granule release. AMPK activation opposes mTORC1 and glycolytic shift, potentially attenuating cytokine-driven NK activation. Spirulina's dual effects, direct NK polysaccharide activation versus indirect AMPK-driven mTORC1 suppression, create a nuanced net outcome: resting NK cells become more active (polysaccharide TLR/dectin stimulation), but cytokine-hyperactivated NK cells may be partially attenuated (AMPK-mTORC1 brake), contributing to immunomodulation rather than pure immunostimulation.

IFN-gamma Production and NK-DC Crosstalk

NK cells are major early IFN-gamma producers in response to IL-12+IL-18 (from DCs/ macrophages). IFN-gamma activates macrophage bactericidal activity, drives Th1 polarisation, and enhances MHC class I expression on target cells (enabling adaptive immune recognition). The NK-DC crosstalk is bidirectional: DCs activate NK cells via IL-12/IL-15/IL-18, and NK cells kill immature DCs (editing the DC pool) while sparing mature DCs (via NKG2A tolerance of HLA-E+ mature DCs). Spirulina's DC maturation effects (polysaccharide-driven IL-12 induction) would stimulate NK IFN-gamma output, contributing to the Th1 bias and anti-tumour surveillance function.